11.04.2016 • NewsRoquetteExcipactSGS

Roquette Receives EXCiPACT Certification

Roquette has recently obtained EXCiPACT certification from SGS France, one of the international auditors authorized to grant approval under this standard.

The certificate demonstrates that the Roquette site at Lestrem, France, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) certification standard. Its scope includes the design, production and storage of excipients made from amylaceous substances such as certain starches and glucoses, sorbitol, maltitol, mannitol and xylitol powders, and maltitol solutions.

EXCiPACT certification ensures top-level quality throughout the entire supply chain and gives customers access to the full documentation mandatory to the regulators.

“This certification is a new milestone in our commitment to customers” said Paul Smaltz, Roquette’s head of Pharma global business unit. “Roquette wants to offer best-in-class services to its customers, and the EXCiPACT certification was a must-have to us. The implementation of quality and safety best practices as required by EXCiPACT offers our customers the possibility to significantly reduce the number of audits. It means for them cost and time savings, while enjoying premium quality products.”

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.